Apremilast associated with improved disease activity and favorable safety profile in psoriatic arthritis: Findings from the Italian MAPSI II Study
Higher baseline CRP Predicts Better TNFi retention, but Not IL-17 Inhibitor Persistence, in Axial Spondyloarthritis
Ivarmacitinib sustained improvements in patient-reported outcomes in moderate-to-severe rheumatoid arthritis
Combination therapy with cyclosporine A and absorbable punctal plugs outperforms monotherapy in Sjögren’s syndrome-associated dry eye
Ixekizumab shows promising efficacy and safety in juvenile psoriatic arthritis and enthesitis-related arthritis
